ADVANCED SOLID MALIGNANCY
Clinical trials for ADVANCED SOLID MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called nenocorilant combined with the immunotherapy nivolumab in people with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. About 50 participants w…
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new oral drug, FX-909, alone or with another drug (pembrolizumab) in people with advanced solid tumors, including a type of bladder cancer. The main goals are to check safety and find the best dose. About 120 adults will take part, taking daily pill…
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New pill shows promise in early cancer trial
Disease control Recruiting nowThis study tests an experimental drug called GRWD5769, taken as a pill, for people with advanced solid tumors that have not responded to standard treatments. The trial has two phases: first, to check safety and find the right dose, and second, to see if the drug shrinks tumors wh…
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Tiny study tracks cancer Drug's journey through the body
Knowledge-focused Recruiting nowThis early-stage study looks at how the experimental drug saruparib is absorbed, distributed, and eliminated in 8 people with advanced solid tumors. Participants will receive the drug by mouth and by vein, with samples taken to track the drug and its breakdown products. The goal …
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC